JP2017513917A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017513917A5 JP2017513917A5 JP2016565186A JP2016565186A JP2017513917A5 JP 2017513917 A5 JP2017513917 A5 JP 2017513917A5 JP 2016565186 A JP2016565186 A JP 2016565186A JP 2016565186 A JP2016565186 A JP 2016565186A JP 2017513917 A5 JP2017513917 A5 JP 2017513917A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- solvate
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461985207P | 2014-04-28 | 2014-04-28 | |
| US61/985,207 | 2014-04-28 | ||
| US201562101768P | 2015-01-09 | 2015-01-09 | |
| US201562176883P | 2015-01-09 | 2015-01-09 | |
| US62/101,768 | 2015-01-09 | ||
| US62/176,883 | 2015-01-09 | ||
| PCT/US2015/027781 WO2015168014A1 (en) | 2014-04-28 | 2015-04-27 | Pharmaceutically active dimers linked through phenolic hydroxyl groups |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017513917A JP2017513917A (ja) | 2017-06-01 |
| JP2017513917A5 true JP2017513917A5 (OSRAM) | 2018-06-14 |
| JP6466970B2 JP6466970B2 (ja) | 2019-02-06 |
Family
ID=53040687
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016565186A Expired - Fee Related JP6466970B2 (ja) | 2014-04-28 | 2015-04-27 | フェノール性ヒドロキシル基を介して連結された医薬的に活性な二量体 |
| JP2016565239A Expired - Fee Related JP6568102B2 (ja) | 2014-04-28 | 2015-04-27 | ブプレノルフィン二量体及び消化管疾患の治療におけるその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016565239A Expired - Fee Related JP6568102B2 (ja) | 2014-04-28 | 2015-04-27 | ブプレノルフィン二量体及び消化管疾患の治療におけるその使用 |
Country Status (25)
| Country | Link |
|---|---|
| US (7) | US9321780B2 (OSRAM) |
| EP (2) | EP3137081B1 (OSRAM) |
| JP (2) | JP6466970B2 (OSRAM) |
| KR (2) | KR102374506B1 (OSRAM) |
| CN (2) | CN106458850B (OSRAM) |
| AU (2) | AU2015253417B2 (OSRAM) |
| CA (2) | CA2945509C (OSRAM) |
| CY (1) | CY1119900T1 (OSRAM) |
| DK (1) | DK3137081T3 (OSRAM) |
| ES (1) | ES2658766T3 (OSRAM) |
| HR (1) | HRP20180260T1 (OSRAM) |
| HU (1) | HUE036084T2 (OSRAM) |
| IL (3) | IL248326B (OSRAM) |
| LT (1) | LT3137081T (OSRAM) |
| MA (1) | MA43129A (OSRAM) |
| ME (1) | ME02946B (OSRAM) |
| MX (3) | MX375600B (OSRAM) |
| PL (1) | PL3137081T3 (OSRAM) |
| PT (1) | PT3137081T (OSRAM) |
| RS (1) | RS56920B1 (OSRAM) |
| SG (3) | SG11201608910UA (OSRAM) |
| SI (1) | SI3137081T1 (OSRAM) |
| SM (1) | SMT201800073T1 (OSRAM) |
| WO (2) | WO2015168014A1 (OSRAM) |
| ZA (2) | ZA201606937B (OSRAM) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3137081T (pt) | 2014-04-28 | 2018-02-08 | Orphomed Inc | Dímero de buprenorfina e o seu uso no tratamento de transtornos gastrointestinais |
| CN108289869B (zh) * | 2014-04-28 | 2021-08-27 | 奥佛麦德公司 | 使用通过酚羟基连接的药学活性的对乙酰氨基酚二聚体治疗疼痛的方法 |
| EP3389628A4 (en) | 2015-12-19 | 2019-08-07 | Dixit, Manesh A. | PHARMACEUTICAL FORMULATIONS OF MOUSE CHEESE TABLETS |
| US20190022013A1 (en) | 2015-12-19 | 2019-01-24 | First Time Us Generics Llc | Soft-chew tablet pharmaceutical formulations |
| US20210113457A1 (en) | 2018-02-02 | 2021-04-22 | Ripple Therapeutics Corporation | Glass formulations and uses thereof |
| US10799496B2 (en) | 2018-07-13 | 2020-10-13 | Alkermes Pharma Ireland Limited | Naphthylenyl compounds for long-acting injectable compositions and related methods |
| WO2020012245A1 (en) | 2018-07-13 | 2020-01-16 | Alkermes Pharma Ireland Limited | Thienothiophene-naltrexone prodrugs for long-acting injectable compositions |
| US10975099B2 (en) | 2018-11-05 | 2021-04-13 | Alkermes Pharma Ireland Limited | Thiophene compounds for long-acting injectable compositions and related methods |
| US12473326B2 (en) | 2019-02-01 | 2025-11-18 | Ripple Therapeutics Corporation | Crystalline forms of dexamethasone dimers and uses thereof |
| US11236067B2 (en) | 2019-07-12 | 2022-02-01 | Orphomed, Inc. | Compound for treating cystic fibrosis |
| WO2021024041A1 (en) * | 2019-08-07 | 2021-02-11 | Ripple Therapeutics Corporation | Controlled release drug dimers |
| CN115956083A (zh) | 2020-05-01 | 2023-04-11 | 波纹疗法公司 | 异二聚体组合物及用于治疗眼部病症的方法 |
| WO2021262763A1 (en) * | 2020-06-23 | 2021-12-30 | Arriba Biopharma, Inc. | Opioid receptor modulator and use thereof |
| CA3259656A1 (en) | 2022-06-22 | 2023-12-28 | Teva Czech Industries S.R.O | SOLID FORMS OF DIBUPENORPHINE ETHYL ETHER AND THEIR PREPARATION PROCESS |
| WO2025014912A1 (en) * | 2023-07-10 | 2025-01-16 | Dimerx, Inc. | Treatment of chronic pain or gastrointestinal disorders using buprenorphine dimer |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3896235A (en) * | 1970-09-01 | 1975-07-22 | Burroughs Wellcome Co | Anthelmintic ethers and composition thereof |
| US5716631A (en) | 1995-09-29 | 1998-02-10 | Rdn Therapeutics Inc. | Long acting narcotic analgesics and antagonists |
| SI1436012T1 (en) * | 2001-10-18 | 2018-03-30 | Nektar Therapeutics | Polymer conjugates of opioid antagonists |
| WO2004039317A2 (en) | 2002-10-25 | 2004-05-13 | Euro-Celtique S.A. | Analogs and prodrugs of buprenorphine |
| CN1263760C (zh) * | 2002-11-12 | 2006-07-12 | 财团法人奇美医院 | 新颖的丁丙诺啡酯衍生物及其制备方法，以及长效作用镇痛药学组合物 |
| DE60224288T2 (de) | 2002-11-25 | 2009-04-16 | Chi Mei Foundation Medical Center | Buprenorphinesterderivate, Verfahren zu ihrer Herstellung, und langwirksame analgetische Arzneimittel |
| JP2004175706A (ja) * | 2002-11-26 | 2004-06-24 | Chi Mei Foundation Medical Center | 新規なブプレノルフィンのエステル誘導体及びそれらの調製方法、及び長時間効力持続性鎮痛薬剤組成物 |
| WO2004103317A2 (en) | 2003-05-15 | 2004-12-02 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for treatment of diarrhea |
| WO2005009377A2 (en) * | 2003-07-23 | 2005-02-03 | University Of Kentucky Research Foundation | Novel oral bioavailable prodrugs |
| CA2609810C (en) | 2005-06-06 | 2012-05-22 | Camurus Ab | Glp-1 analogue formulations |
| US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
| DK2001456T3 (da) | 2006-04-04 | 2010-04-12 | Emodys Gmbh | Anvendelse af kappa-opiodreceptorantagonistholde sammensætninger til behandling af dissociative forstyrrelser |
| CN101466381B (zh) | 2006-04-21 | 2012-11-14 | 尼克塔治疗公司 | 吗啡酮的立体选择性还原 |
| MY156913A (en) | 2008-05-07 | 2016-04-15 | Nektar Therapeutics | Oral administration of peripherally-acting opioid antagonists |
| US20100068786A1 (en) | 2008-09-16 | 2010-03-18 | Chmielewski Jean A | Methods and compositions for reversing p-glycoprotein medicated drug resistance |
| US8461171B2 (en) * | 2010-02-09 | 2013-06-11 | QRxPharma Ltd. | Hybrid opioid compounds and compositions |
| GB2513267B (en) | 2010-06-08 | 2015-03-18 | Rb Pharmaceuticals Ltd | Injectable flowable composition comprising buprenorphine |
| KR101793101B1 (ko) | 2010-08-20 | 2017-11-02 | 닥터 레디스 래보러토리즈 에스에이 | 인지질 데포 |
| CN103289075B (zh) * | 2012-02-22 | 2016-01-20 | 天津键凯科技有限公司 | 聚乙二醇与纳洛酮的结合物及其药物组合物和应用 |
| PT3137081T (pt) * | 2014-04-28 | 2018-02-08 | Orphomed Inc | Dímero de buprenorfina e o seu uso no tratamento de transtornos gastrointestinais |
-
2015
- 2015-04-27 PT PT157202441T patent/PT3137081T/pt unknown
- 2015-04-27 DK DK15720244.1T patent/DK3137081T3/da active
- 2015-04-27 MX MX2016013829A patent/MX375600B/es active IP Right Grant
- 2015-04-27 HR HRP20180260TT patent/HRP20180260T1/hr unknown
- 2015-04-27 KR KR1020167032992A patent/KR102374506B1/ko not_active Expired - Fee Related
- 2015-04-27 SG SG11201608910UA patent/SG11201608910UA/en unknown
- 2015-04-27 HU HUE15720244A patent/HUE036084T2/hu unknown
- 2015-04-27 JP JP2016565186A patent/JP6466970B2/ja not_active Expired - Fee Related
- 2015-04-27 ME MEP-2018-31A patent/ME02946B/me unknown
- 2015-04-27 US US14/697,174 patent/US9321780B2/en active Active
- 2015-04-27 SM SM20180073T patent/SMT201800073T1/it unknown
- 2015-04-27 EP EP15720244.1A patent/EP3137081B1/en active Active
- 2015-04-27 LT LTEP15720244.1T patent/LT3137081T/lt unknown
- 2015-04-27 CA CA2945509A patent/CA2945509C/en active Active
- 2015-04-27 SI SI201530180T patent/SI3137081T1/en unknown
- 2015-04-27 CN CN201580023293.8A patent/CN106458850B/zh active Active
- 2015-04-27 AU AU2015253417A patent/AU2015253417B2/en active Active
- 2015-04-27 ES ES15720244.1T patent/ES2658766T3/es active Active
- 2015-04-27 WO PCT/US2015/027781 patent/WO2015168014A1/en not_active Ceased
- 2015-04-27 EP EP15720242.5A patent/EP3137080B1/en active Active
- 2015-04-27 JP JP2016565239A patent/JP6568102B2/ja not_active Expired - Fee Related
- 2015-04-27 WO PCT/US2015/027820 patent/WO2015168031A1/en not_active Ceased
- 2015-04-27 AU AU2015253434A patent/AU2015253434B2/en active Active
- 2015-04-27 KR KR1020167032991A patent/KR102452348B1/ko active Active
- 2015-04-27 SG SG11201608918SA patent/SG11201608918SA/en unknown
- 2015-04-27 PL PL15720244T patent/PL3137081T3/pl unknown
- 2015-04-27 CA CA2945181A patent/CA2945181C/en active Active
- 2015-04-27 US US14/697,155 patent/US9309256B2/en active Active
- 2015-04-27 CN CN201580023367.8A patent/CN106470999B/zh active Active
- 2015-04-27 RS RS20180148A patent/RS56920B1/sr unknown
- 2015-04-27 MX MX2016013823A patent/MX375597B/es active IP Right Grant
- 2015-10-26 US US14/922,362 patent/US9480665B2/en active Active
- 2015-10-26 US US14/922,373 patent/US9549924B2/en active Active
-
2016
- 2016-03-18 US US15/074,960 patent/US9732096B2/en active Active
- 2016-03-18 US US15/074,933 patent/US20160368931A1/en not_active Abandoned
- 2016-10-04 US US15/285,312 patent/US9782369B2/en active Active
- 2016-10-10 ZA ZA2016/06937A patent/ZA201606937B/en unknown
- 2016-10-13 IL IL248326A patent/IL248326B/en active IP Right Grant
- 2016-10-13 IL IL248324A patent/IL248324B/en active IP Right Grant
- 2016-10-25 MA MA043129A patent/MA43129A/fr unknown
- 2016-10-25 SG SG11201803266XA patent/SG11201803266XA/en unknown
- 2016-10-25 MX MX2018004834A patent/MX376379B/es active IP Right Grant
-
2018
- 2018-02-12 CY CY20181100169T patent/CY1119900T1/el unknown
- 2018-04-17 IL IL258762A patent/IL258762B/en active IP Right Grant
- 2018-04-20 ZA ZA2018/02643A patent/ZA201802643B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017513917A5 (OSRAM) | ||
| JP2015078230A5 (OSRAM) | ||
| JP2013032389A5 (OSRAM) | ||
| JP2013518107A5 (OSRAM) | ||
| JP2017514910A5 (OSRAM) | ||
| JP2011527299A5 (OSRAM) | ||
| JP2011105738A5 (OSRAM) | ||
| CL2017000379A1 (es) | Compuestos de pirrolopirimidina usados como agonistas del receptor de tipo toll. 7 (tlr7) | |
| JP2016515561A5 (OSRAM) | ||
| JP2013509429A5 (OSRAM) | ||
| JP2016501221A5 (OSRAM) | ||
| JP2015537020A5 (OSRAM) | ||
| JP2014521688A5 (OSRAM) | ||
| PE20151318A1 (es) | Analogos de 2'-cloro nucleosido para infeccion por vhc | |
| JP2013014622A5 (OSRAM) | ||
| JP2019510027A5 (OSRAM) | ||
| JP2013542261A5 (OSRAM) | ||
| JP2017517565A5 (OSRAM) | ||
| RU2015149527A (ru) | Производные доластатина 10 и ауристатинов | |
| JP2014500861A5 (OSRAM) | ||
| JP2020097577A5 (OSRAM) | ||
| SI3137081T1 (en) | BUPRENORFIN DIMER AND ITS USE IN HEALTHY DISEASE DISEASES | |
| MX2016008665A (es) | Derivado basado en 1,2-naftoquinona y metodo de preparacion del mismo. | |
| JP2015509075A5 (OSRAM) | ||
| PH12015501945A1 (en) | Formulations of organic compounds |